Old Web
English
Sign In
Acemap
>
authorDetail
>
Thorsten Meyer
Thorsten Meyer
GPC Biotech
Chromatography
Chemistry
Lymphoma
Antibody
Immunology
3
Papers
46
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I study.
2012
Cancer Immunology, Immunotherapy
Carmen D. Schweighofer
Armin Tuchscherer
Sabine Sperka
Thorsten Meyer
Benno Rattel
Sandra Stein
Semra Ismail
Thomas Elter
Peter Staib
Marcel Reiser
Michael Hallek
Show All
Source
Cite
Save
Citations (6)
Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry
2009
Journal of Pharmaceutical and Biomedical Analysis
Peter de Bruijn
Inge M. Ghobadi Moghaddam-Helmantel
Maja J.A. de Jonge
Thorsten Meyer
Mei-Ho Lam
Jaap Verweij
Erik A.C. Wiemer
Walter J. Loos
Show All
Source
Cite
Save
Citations (18)
COMPARATIVE PROTEIN BINDING, STABILITY AND DEGRADATION OF SATRAPLATIN, JM118 AND CISPLATIN IN HUMAN PLASMA IN VITRO
2008
Clinical and Experimental Pharmacology and Physiology
Deanna N. Bell
Johnson J. Liu
Malcolm D. Tingle
Benno Rattel
Thorsten Meyer
Mark J. McKeage
Show All
Source
Cite
Save
Citations (22)
1